BREAKING NEWS!: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer. Read More.
Go here to learn more or to get a mailed copy.
Home » Archives for September 2018
A PCF Young Investigator takes on prostate cancer tumor cells that “change their identity” Ping Mu is a research associate working at Memorial Sloan Kettering Cancer Center and a PCF...Read More
Muhit Rahman Takes on The Grand To Grand Ultra Marathon to Raise Money For Prostate Cancer In the last few minutes of our interview this week at the Prostate...Read More
So you’ve had your PSA test, and it came back high. Your doctor did a DRE and ran a few more tests, and assures you that prostate cancer is very...Read More
The physiology of your body has a lot to do with cancer As Suzanne Conzen, MD (University of Chicago) knows, there isn’t any question that there is an interaction between...Read More